Oncosil Medical Ltd has released a press release.
Appendix 4E Preliminary Financial Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Successful Treatment with OncoSil Device in Turkiye
- Australian institution to invest $2.7 million in OSL
- $5.3 million raised under Entitlement Offer
- 1st Study in Man Increases Pancreatic Tumor Vascularity
- First patient treated with OncoSil device in Turkiye
Later from OncoSil Medical
- G-BA Approval received for OncoSil Device
- OSL completes $7 M Placement and announces $1 M SPP
- Prospectus 2024 Share Purchase Plan (SPP) Offer
- Oncosil completes $1 million Share Purchase Plan (SPP)
- OncoSil receives $1.05m R&D tax incentive
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical